Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence

Autor: Wai T. Wong, Trent Tsun-Kang Chiang, Catherine A Cukras, Jennifer Liao, Tiarnan D L Keenan, Elvira Agrón, Emily Y. Chew, B. E. K. Klein
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
medicine.medical_specialty
Visual acuity
genetic structures
Fundus Oculi
Visual Acuity
Retinal Drusen
subretinal drusenoid deposits
Drusen
Lower risk
Severity of Illness Index
Retina
macular thickness
Macular Degeneration
outcome measures
03 medical and health sciences
0302 clinical medicine
Disease severity
Age related
Ophthalmology
Severity of illness
Humans
Medicine
Macula Lutea
Prospective Studies
Fluorescein Angiography
Prospective cohort study
Aged
optical coherence tomography
business.industry
reticular pseudodrusen
Macular degeneration
medicine.disease
eye diseases
Cross-Sectional Studies
intermediate age-related macular degeneration
030104 developmental biology
030221 ophthalmology & optometry
Female
sense organs
medicine.symptom
business
Tomography
Optical Coherence

Follow-Up Studies
Zdroj: Investigative Ophthalmology & Visual Science
ISSN: 1552-5783
DOI: 10.1167/iovs.61.6.59
Popis: Purpose To investigate how macular thickness varies with intermediate age-related macular degeneration (iAMD) severity and the presence of subretinal drusenoid deposits (SDDs). Methods A longitudinal prospective study of 143 participants >50 years of age with no to intermediate AMD who were followed with multimodal imaging and functional testing. Participants were stratified by iAMD severity according to imaging features. Macular thicknesses measurements over the central circles with 1-mm, 3-mm, and 6-mm diameters obtained from ocular coherence tomography imaging were compared across severity categories using cross-sectional (143 eyes) and longitudinal (subset of 77 eyes followed for 4 years) multivariate analyses. Results Compared with control eyes without large drusen or SDDs (Group 0), central maculas of lower risk eyes with unilateral large drusen (Group 1) were thicker (P = 0.014), whereas higher risk eyes with SDDs (Group SDD) were thinner (P = 0.02) in cross-sectional multivariate analyses. In longitudinal analyses, maculas with SDDs thinned more rapidly over 4 years relative to control eyes (P = 0.0058), which did not show significant thinning. More rapid central macular thinning was associated with worse baseline best-corrected visual acuity (BCVA) (P = 0.016) and more rapid BCVA decline (P = 0.0059). Conclusions Macular thickness in iAMD varies with disease severity, showing small increases in eyes with large drusen and decreases in eyes with SDDs. Active processes possibly related to neuroinflammation and neurodegeneration may be contributory. Longitudinal central macular thickness evaluation is an accessible outcome measure relevant to functional measures and is potentially useful for iAMD interventional studies.
Databáze: OpenAIRE